Heart failure daily pill a ‘beacon of hope’ for thousands of sufferers
A pioneering drug that targets a life-threatening heart condition is “a beacon of hope” for thousands of sufferers, says a businessman given five years to live. Peter Salussolia, 80, from South West London, was diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR-CM) in 2018. The potentially fatal condition causes clumps of protein to build up in the heart, … Read more
